Steven Cohen Neuronetics, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $191 - $456	68 New	68 $0
Q1 2019 May 15, 2019	SELL	$13.6 - $19.58 $5.15 Million - $7.41 Million	-378,359 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $2.18 Million - $4.35 Million	136,507 Added 56.44%	378,359 $7.32 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $5.15 Million - $7.95 Million	211,852 Added 706.17%	241,852 $7.75 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $798,300 - $833,400	30,000 New	30,000 $798,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.